• Atomo Diagnostics closed its Share Purchase Plan, raising $44,500 before costs
• The Company received valid applications for 1,348,480 shares
• Applicants will also receive 674,229 free attaching options

Atomo Diagnostics Limited (ASX: AT1) has announced the results of its Share Purchase Plan (SPP), which closed on 8 May 2026. The Company received valid applications for 1,348,480 shares, raising $44,500 before costs. The Directors have accepted all valid applications in full. The Applicants will also receive 674,229 free attaching options, exercisable at $0.045 (4.5 cents), expiring 2.5 years from the date of issue. Under the SPP, shareholders in the Company registered in Australia and New Zealand on the record date of 27 March 2026 were entitled to subscribe for up to $30,000 of new fully paid ordinary shares at an issue price of $0.033 (3.3 cents) per share. The Company reserves the right to place the SPP Shortfall which amounts to $955,500. The new shares will rank equally with existing shares in the Company. The SPP Shares are to be issued on 15 May 2026. Managing Director & CEO, John Kelly, commented that the raising will allow the Company to move forward with its operational activities.